GlassScriptPhysician profile
Gregory W Pippin
NPI 1700966090
$6,478.94
in general payments reported to CMS, 2019-2025
22 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $735 · 2021: $542 · 2022: $950 · 2023: $1,021 · 2024: $933 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372 · Travel and Lodging: $884 · Honoraria: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,371.80 |
| Travel and Lodging | $884.14 |
| Honoraria | $505.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,087.11 | 2020-2025 | |
| Stryker Corporation | $1,289.29 | 2019-2024 | Scopis Ent, Xpress Loprofile, Xpress Ent Dilation System |
| Smith+Nephew, INC. | $1,018.59 | 2025 | Coblation, Tula |
| Ambu A/S | $505.00 | 2025 | |
| Acclarent, INC | $273.94 | 2019-2020 | |
| Intersect Ent, INC. | $265.50 | 2020-2021 | |
| Biotissue Holdings INC. | $172.98 | 2025 | |
| Arrinex, INC. | $160.31 | 2019 | |
| Allergan, INC. | $115.41 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $112.73 | 2021-2024 | Dupixent |
| Medtronic, INC. | $110.82 | 2021-2025 | Propel |
| Glaxosmithkline, LLC. | $98.88 | 2021-2023 | Nucala |
| Genzyme Corporation | $70.93 | 2021-2022 | |
| Optinose US, INC. | $61.58 | 2019-2023 | |
| Olympus America INC. | $27.84 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $23.12 | 2021 | |
| Uswm, LLC | $19.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.38 | 2025 | |
| Merck Sharp & Dohme LLC | $14.72 | 2023 | |
| Hikma Pharmaceuticals USA | $13.09 | 2024 | Ryaltris |
| Cook Medical LLC | $11.43 | 2019 | |
| Greer Laboratories, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Pippin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.